← Back to catalogue

MEDRAD® Salient Contrast Injection System

EUDAMED

Class IIb (EU MDR)

Ref DC009SW

by Imaxeon Pty Ltd

Identity

Trade Name
MEDRAD® Salient Contrast Injection System EUDAMED
Device Name
MEDRAD® Salient Contrast Injection System EUDAMED
Model / Reference
DC009SW EUDAMED

Identifiers

Primary DI / UDI-DI
09345390000744 EUDAMED
Basic UDI-DI
934539000TFCN-0102UU EUDAMED
EMDN Code
Z11039013 ANGIOGRAPHIC INJECTORS EUDAMED

Classification

Device Class
Class IIb EUDAMED
Market of Registration
Netherlands EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

Yes

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

The MEDRAD Salient Contrast Injection System is a medical device designed for the administration of contrast agents in radiology, providing high-quality images with minimal radiation exposure. With its advanced technology and user-friendly interface, this system enables healthcare professionals to deliver precise and effective treatments.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Imaxeon Pty Ltd
EUDAMED SRN
AU-MF-000009702
Authorised Representative
Bayer Medical Care B.V. NL-AR-000000240

Sources (1)

  • EUDAMED e26e238a-b265-47ab-8959-89bd5eb28cee 61 fields · synced Jun 28, 2026